Back to PRLD

GOLDMAN SACHS GROUP INC → PRLD

GOLDMAN SACHS GROUP INC PRLD Position History

Prelude Therapeutics Incorporated • Healthcare

Quarters held
12
Latest value
$61K
Q3 2026
Peak value
$1.7M
First seen
Q1 2025

Dollar value over time

Show data table
PeriodPosition value
Q1 2025$107K
Q1 2025$13K
Q2 2025$121K
Q3 2025$114K
Q4 2025$341K
Q4 2025$341K
Q1 2026$809K
Q2 2026$265K
Q2 2026$379K
Q3 2026$1.7M
Q3 2026$888K
Q3 2026$61K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$61K15.5K——
Q3 2026$888K227.0K——
Q3 2026$1.7M424.3K——
Q2 2026$379K71.1K——
Q2 2026$265K49.8K——
Q1 2026$809K236.5K——
Q4 2025$341K117.5K——
Q4 2025$341K117.5K——
Q3 2025$114K79.3K——
Q2 2025$121K149.2K——
Q1 2025$13K16.4K——
Q1 2025$107K138.8K——

Other funds holding PRLD

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B